Jco Precision Oncology

雜志介紹

Jco Precision Oncology雜志介紹

《Jco Precision Oncology》是一本以English為主的混合獲取國際優秀期刊，中文名稱Jco精準腫瘤學，本刊主要出版、報道醫學-腫瘤學領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCI、SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.7，最新CiteScore 指數為6.2。

本刊近期中國學者發表的論文主要有：

• Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substud

  Author: Duan, Yuqing; Hashimoto, Tadayoshi; Shibuki, Taro; Taniguchi, Hiroya; Sunakawa, Yu; Komatsu, Yoshito; Takahashi, Naoki; Sato, Yuta; Yamaguchi, Kensei; Nishina, Tomohiro; Nakanoko, Tomonori; Boku, Shogen; Satoh, Taroh; Yasui, Hisateru; Esaki, Taito; Imai, Mitsuho; Fujisawa, Takao; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki

• Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics Analysi

  Author: Liu, Pengcheng; Chen, Zhongxu; Hong, Hui; Sun, Yihua

• Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective Analysi

  Author: Lin, Ke; Wang, Cailun; Qiao, Bin; Zhang, Nan; Yang, Daopeng; Jin, Dongdong; Li, Cong; Lv, Jingsen; He, Minghui; Lin, Zhao; Xie, Xiaohua; Xie, Xiaoyan; Zhuang, Bowen

• Foundation Model Based on Routine Magnetic Resonance Imaging for Brain Tumor Molecular Profiling and Progression Predictio

  Author: Li, Junxian; Liu, Renhe; Xing, Yuchen; Gao, Ximin; Yin, Qiang; Su, Qian

英文介紹

Jco Precision Oncology雜志英文介紹

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).